EP0201568A1 - Vaccins anthelminthiques comprenant une espece de nematode - Google Patents

Vaccins anthelminthiques comprenant une espece de nematode

Info

Publication number
EP0201568A1
EP0201568A1 EP85905735A EP85905735A EP0201568A1 EP 0201568 A1 EP0201568 A1 EP 0201568A1 EP 85905735 A EP85905735 A EP 85905735A EP 85905735 A EP85905735 A EP 85905735A EP 0201568 A1 EP0201568 A1 EP 0201568A1
Authority
EP
European Patent Office
Prior art keywords
species
parasitic
mammals
birds
vaccine preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP85905735A
Other languages
German (de)
English (en)
Inventor
Gary Stewart Cobon
David Bruce Adams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Biotech Australia Pty Ltd
Inhibin Pty Ltd
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Biotech Australia Pty Ltd
Biotechnology Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO, Biotech Australia Pty Ltd, Biotechnology Australia Pty Ltd filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Publication of EP0201568A1 publication Critical patent/EP0201568A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens

Definitions

  • the present invention relates to vaccines, particularly anthelmlnthic vaccines.
  • parasitic nematodes may have altered their antigen profile to one which resembles that of the host so that in a natural infection, vigorous immunological reactions are not provoked by important (protective) parasite antigens. This would also occur following vaccination with killed preparations or extracts of the nematodes.
  • a third possibility is that the readily abundant L3 developmental stage of parasites which have been used as a source of antigens in the majority of these studies may not contain the potentially protective antigens associated with the parasitic L4, L5 and adult stages of the nematodes. Limited availability of the parasitic stages precludes their use in large scale vaccines even if they were protective as these parasitic nematodes cannot be readily cultivated In vitro beyond the L3 stage.
  • the present invention results from the discovery by the present inventors that nematode species which are non parasitic to mammals or birds contain antigens which 'cross react with antibodies produced by mammals or birds which have been infected with or vaccinated with extracts of parasitic nematodes. Therefore it is considered that vaccine preparations derived from a readily cultivated species of nematode non-parasitic to mammals or birds may be used to vaccinate and successfully protect mammals or birds from infections by nematode species which are parasitic to said mammals or birds, even though the species used to derive the vaccine is not the same and may be classified in a - 3 - different order or even a different class from the parasitic species.
  • a vaccine preparation for the vaccination of mammals or birds against infections by nematodes parasitic thereto comprising an homogenate, or an extract thereof, of at least one species of nematode which is non-parasitic to mammals.
  • a method of vaccinating mammals or birds against parasitic nematode Infections comprising vaccinating the mammal or bird with an effective amount of a suspension, homogenate or extract of a nematode species which is not parasitic to said mammals or birds.
  • the vaccine preparation comprises a suspension of at least one species of a nematode, non-parasitic to mammals or birds, wherein the nematodes have been killed or inactivated.
  • the vaccine preparations of the present invention are adapted for introduction into the mammalian o * avian system preferably by injection. Therefore, preferably the homogenate and/or extract is sterilised by, e.g. filtration through a small pore filter, the inclusion of antibacterial compounds, formalinisation or other methods known in the art ' . When killed nematode suspensions are used, the nematodes are killed by methods known to those skilled in the art, such as by formalinisation.
  • the active ingredients in the vaccine preparation may be delivered in the presence of any of the adjusments known in the art of the vaccine preparation, such as aluminium salt precipitates or oily based adjuvants such as Freund's adjuvants.
  • the amount of active ingredients incorporated into the vaccines will vary depending on the size of the animal or bird being vaccinated, the adjuvant used and the purity of the active ingredient. Thus doses from as little as 10 ⁇ g to 500 mg of dry weight of material may be required. Preferably dosage will be in the range of 50 ⁇ g to lmg.
  • the species of nematode used for incorporation into the vaccine will preferably be readily cultivated in vitro. This enables the availability of sufficient quantities of all stages of development for incorporation into a commercial vaccine. More mature developmental stages may quantitatively and/or qualitatively be a superior source than juvenile forms.
  • Figure 1 illustrates the immunological cross reactivity between parasitic and free living nematodes.
  • Figure 1A demonstrates that antiserum from sheep vaccinated with homogenates of Haemonchous contortus adults, a parasitic nematode, reacted with antigens from homogenates of free living nematodes.
  • Figure IB demonstrates that antiserum from sheep vaccinated with homogenates of Haemonchous contortus larvae reacted with antigens from homogenates of free living nematodes.
  • Figure 1C demonstrates that antiserum from sheep vaccinated with homogenates of Stelnernema feltiae, a free living nematode, exhibits cross-reactivity with homogenates of parasitic nematodes.
  • the vaccinating nematode need not be a member of the same family, superfamily, suborder, order or possibly even class as the parasitic species.
  • a member of the order Rhabditida (Stelnernema feltiae Mexican) can provide protection of sheep against infection by a member of the order Strongylida (Haemonchus contortus) . Therefore a large number of species would be suitable for incorporation into a vaccine but would preferably be readily cultivated in vitro such as are members of the
  • Stelnernema e.g. S_. feltiae
  • Caenorhabditis e.g. C.elegans
  • Heterorhabditis e.g. H. heltiothldis
  • US Patents 4,178,366 and 4.334,498 disclose methods for large scale iri vitro cultivation of such nematodes.
  • the parasitic nematode species against which vaccination would be expected. to be effective are similarly numerous. In the example presented, protection is observed against a member of the order Strongylida (Haemonchus contortus) by vaccination with extract from a member of the order Rhabditia (Stelnernema feltlae Mexican) .
  • Trichinella spiralls infections of pigs, Toxascaris leonina or Uncinarla stenocephala infections of cats and Ancylostoma caninum or Trichurls vulpls infections of dogs would be expected to be effectively vaccinated against.
  • the vaccine would be expected to be effective against nematodes which parasitise tissues other than gastro-intestinal tract.
  • the vaccine would be expected to be effective against infections of the circulatory system of man by larvae of Texocara spp and of the circulatory system of dogs by Dirofilaria immitls as well as infections of the circulatory system, urogenital system, respiratory system, skin and subcutaneous tissues of these and other species of animal. It should be noted that this list is by no means complete. The invention will be further described with reference to the following examples. Example 1
  • Fig 1A Haemonchus contortus adults
  • Fig IB Haemonchous contortus infective larvae
  • Fig IB Stelnernema feltlae larvae
  • Example 2 Three sheep were vaccinated with an homogenate obtained by ultrasonication of Stelnernema feltlae (Mexican) . The sheep received two vaccinations subcutaneously in the absence of adjuvant four weeks apart, each vaccination being the equivalent of 83mg wet weight of nematodes per kg body weight of sheep. Three weeks after the second vaccination the sheep and five non vaccinated infection controls were challenged with 10,000 infective larvae of Haemonchus contortus. On days 23, 27, 29, 33, 36 and 40 post infection faecal egg counts were performed on all sheep. The result (eggs/g faeces) are presented in the Table 1, below. - 7 -

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Une préparation de vaccin comprend une suspension, un homogénat ou un extrait d'une espèce de nématode non parasite de mammifères ou d'oiseaux, et un excipient et/ou diluant pharmaceutiquement acceptable. Ce vaccin est utile pour immuniser des mammifères et des oiseaux contre d'autres espèces de nématodes parasites de ces mammifères et de ces oiseaux.
EP85905735A 1984-11-15 1985-11-15 Vaccins anthelminthiques comprenant une espece de nematode Withdrawn EP0201568A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPG814584 1984-11-15
AU8145/84 1984-11-15

Publications (1)

Publication Number Publication Date
EP0201568A1 true EP0201568A1 (fr) 1986-11-20

Family

ID=3770842

Family Applications (1)

Application Number Title Priority Date Filing Date
EP85905735A Withdrawn EP0201568A1 (fr) 1984-11-15 1985-11-15 Vaccins anthelminthiques comprenant une espece de nematode

Country Status (7)

Country Link
EP (1) EP0201568A1 (fr)
ES (1) ES8705231A1 (fr)
GR (1) GR852768B (fr)
IL (1) IL77061A0 (fr)
NZ (1) NZ214215A (fr)
WO (1) WO1986002839A1 (fr)
ZA (1) ZA858789B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2152510B (en) * 1984-01-10 1988-06-15 Kenneth K Lew Method for the commercial production of helminths antigens
GB8619293D0 (en) * 1986-08-07 1986-09-17 Munn E A Anthelmintic agents
GB8906156D0 (en) * 1989-03-17 1989-05-04 Munn Edward A Production and use of anthelmintic agents and protective immunogens
GB9322702D0 (en) 1993-11-03 1993-12-22 Agricultural & Food Res Vaccines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657415A (en) * 1963-10-10 1972-04-18 Univ Dundee Canine hookworm vaccines
ZA706513B (en) * 1969-10-03 1971-07-28 Univ Dundee Process for the production of a vaccine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8602839A1 *

Also Published As

Publication number Publication date
ZA858789B (en) 1986-08-27
NZ214215A (en) 1988-07-28
ES548889A0 (es) 1987-05-01
GR852768B (fr) 1986-03-12
WO1986002839A1 (fr) 1986-05-22
IL77061A0 (en) 1986-04-29
ES8705231A1 (es) 1987-05-01

Similar Documents

Publication Publication Date Title
Wallach et al. Eimeria maxima gametocyte antigens: potential use in a subunit maternal vaccine against coccidiosis in chickens
US4724145A (en) Eimeria acervulina immunogens
Smith et al. Evaluation of aspects of the protection afforded to sheep immunised with a gut membrane protein of Haemonchus contortus
Schad The role of arrested development in the regulation of nematode populations
CZ290810B6 (cs) Očkovací látka pro in ovo očkování domestikovaných ptáků proti kokcidióze
Boulanger et al. Vaccination of goats against the trematode Schistosoma bovis with a recombinant homologous schistosome‐derived glutathione S‐transferase
BLAIR et al. Immunization of ferrets against Diroflaria immitis by means of chemically abbreviated infections
JP2001516205A (ja) 単離された寄生体腸管生細胞
JP2018512152A (ja) 鳥類ワクチン
AU573407B2 (en) Anthelmintic vaccines comprising a nematode species
EP0201568A1 (fr) Vaccins anthelminthiques comprenant une espece de nematode
Dubey et al. Immunity to toxoplasmosis in pigs fed irradiated Toxoplasma gondii oocysts
Bancroft et al. The analysis of the humoral response of the BALB/c mouse immunized with radiation attenuated third stage larvae of Brugia pahangi
US4761281A (en) Vaccine from Dirofilaria extracts
US4473548A (en) Method of immunizing cats against shedding of Toxoplasma oocysts
CA2356452A1 (fr) Compositions et procedes pour reduire ou prevenir la fertilisation chez des poissons et des oiseaux
US6790457B1 (en) Compositions and methods for reducing or preventing fertilization in fish and birds
Garcia-Allan et al. Immunocharacterization of Taenia solium oncosphere and metacestode antigens
Rickard et al. Studies on the fate of Taenia hydatigena and Taenia ovis larvae in rabbits, and cross-immunity with Taenia pisiformis larvae
Kerr Studies on the transmission of experimental yellow fever by Culex thalassius and Mansonia uniformis
US20050118194A1 (en) Oral vaccine, method for its preparation and use thereof
Roberts et al. Studies on resistance in calves to experimental infection with the nodular worm, Oesophagostomum radiatum (Rudolphi 1803). II. The role of the respective stages of the parasitic life cycle in the stimulation of resistance
Hertzberg et al. Development of a Protective Immunity againstOstertagia leptospicularisin Trickle-infected Sheep and Parallel Changes of Serum Gastrin, Pepsinogen and Antibody Levels
Poynter Parasitic bronchitis
Nansen et al. The effect of experimental trichostrongyle infections of housed young calves on the subsequent course of natural infection on pasture

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19861016

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ADAMS, DAVID BRUCE

Inventor name: COBON, GARY, STEWART